1. Home
  2. AIEV vs MYNZ Comparison

AIEV vs MYNZ Comparison

Compare AIEV & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIEV
  • MYNZ
  • Stock Information
  • Founded
  • AIEV 2011
  • MYNZ 2021
  • Country
  • AIEV United States
  • MYNZ Germany
  • Employees
  • AIEV N/A
  • MYNZ N/A
  • Industry
  • AIEV Blank Checks
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIEV Finance
  • MYNZ Health Care
  • Exchange
  • AIEV Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • AIEV 6.9M
  • MYNZ 7.2M
  • IPO Year
  • AIEV N/A
  • MYNZ 2021
  • Fundamental
  • Price
  • AIEV $0.02
  • MYNZ $3.20
  • Analyst Decision
  • AIEV
  • MYNZ Buy
  • Analyst Count
  • AIEV 0
  • MYNZ 2
  • Target Price
  • AIEV N/A
  • MYNZ $14.00
  • AVG Volume (30 Days)
  • AIEV 409.8K
  • MYNZ 105.1K
  • Earning Date
  • AIEV 05-15-2025
  • MYNZ 05-06-2025
  • Dividend Yield
  • AIEV N/A
  • MYNZ N/A
  • EPS Growth
  • AIEV N/A
  • MYNZ N/A
  • EPS
  • AIEV N/A
  • MYNZ N/A
  • Revenue
  • AIEV N/A
  • MYNZ $893,991.00
  • Revenue This Year
  • AIEV N/A
  • MYNZ $42.95
  • Revenue Next Year
  • AIEV N/A
  • MYNZ N/A
  • P/E Ratio
  • AIEV N/A
  • MYNZ N/A
  • Revenue Growth
  • AIEV N/A
  • MYNZ N/A
  • 52 Week Low
  • AIEV $0.05
  • MYNZ $0.18
  • 52 Week High
  • AIEV $12.12
  • MYNZ $8.20
  • Technical
  • Relative Strength Index (RSI)
  • AIEV N/A
  • MYNZ 40.90
  • Support Level
  • AIEV N/A
  • MYNZ $3.03
  • Resistance Level
  • AIEV N/A
  • MYNZ $3.31
  • Average True Range (ATR)
  • AIEV 0.00
  • MYNZ 0.35
  • MACD
  • AIEV 0.00
  • MYNZ 0.06
  • Stochastic Oscillator
  • AIEV 0.00
  • MYNZ 61.80

About AIEV Thunder Power Holdings Inc. Common Stock

Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: